Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00429923
Status:
COMPLETED
Last Update Posted:
2009-07-02
First Post:
2007-01-31
Brief Title:
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery ST-601A-002a
Sponsor:
Sirion Therapeutics Inc
Organization:
Sirion Therapeutics Inc
Study Overview
Official Title:
A Phase 3 Multicenter Randomized Double-Masked Placebo-Controlled Study of the Safety and Efficacy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery
Status:
COMPLETED
Status Verified Date:
2009-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this phase III study is to determine the efficacy of difluprednate in the treatment of inflammation following ocular surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None